Key result
Intracranial arteries resist atherosclerosis in mice, linked to elevated tight junction proteins and HO-1 expression.
Why the study?
Intracranial atherosclerosis is a common cause of stroke and dementia, but limited data exist on its occurrence in mice to establish a relevant animal model.
Absolute Event Rate: 0% vs 100%
Intracranial arteries possess intrinsic resistance to atherosclerosis compared to extracranial vessels, which may be mediated by unique morphological features and enhanced antioxidant defenses via the HO-1/NRF2 pathway.
Mouse models show intracranial arterial resistance via HO-1; hypothesis-generating for cerebrovascular protection but requires human validation before any clinical consideration.
Although mice are used extensively to study atherosclerosis of different vascular beds, limited data are published on the occurrence of intracranial atherosclerosis. Since intracranial atherosclerosis is a common cause of stroke and is associated with dementia, a relevant animal model is needed to study these diseases. We examined the presence of intracranial atherosclerosis in different atherogenic mouse strains and studied differences in vessel wall characteristics in mouse and human tissue in search of possible explanations for the differing atherosclerotic susceptibility between extracranial and intracranial vessels. The presence of atherosclerotic plaques was systematically examined from the distal common carotids to the circle of Willis in three atherogenic mouse models. Extra- and intracranial vessel characteristics were studied by immunohistochemistry. All three strains developed atherosclerotic lesions in the common carotids, while no lesions were found intracranially. This coincided with altered vessel morphology. Compared to extracranial sections, intracranially the number of elastic layers decreased, tight junction markers increased, and antioxidant enzyme heme oxygenase (HO)-1 increased. Higher HO-1 expression was also shown in human intracranial arteries. Human brain endothelial cell stimulation with oxidized LDL induced endogenous protective antioxidant HO-1 levels through NRF2 translocation. Intracranial atherosclerosis was absent in three atherogenic mouse models. Intracranial vessel segments showed an increased presence of junction markers in mice and increased HO-1 in both mice and human tissue. We suggest that differences in brain vessel structure and induced antioxidant levels in the brain endothelium found in mouse and human tissue may contribute to the decreased atherosclerosis susceptibility of intracranial arteries.
No takes yet. Share an insight, caveat, or question.
Bink et al. (2025) studied Atherosclerosis (n=61). Intracranial vascular beds vs. Extracranial vascular beds was evaluated on Presence of atherosclerotic lesions. Intracranial atherosclerosis was completely absent in atherogenic mouse models despite severe extracranial lesions, correlating with increased intracranial expression of tight junction markers and the antioxidant enzyme HO-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: